By comparison, the loci we identified for glycine that were most strongly associated with CAD (PIGV, TRIB1, and SLC22A3) had smaller effect sizes on glycine levels than CPS1 and GLDC. The gene discussed is SLC22A3; the disease is coronary artery disorder.